BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34363903)

  • 1. The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance.
    Chandra Jena B; Sarkar S; Rout L; Mandal M
    Cancer Lett; 2021 Nov; 520():222-232. PubMed ID: 34363903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
    Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
    J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation.
    Coleman DT; Gray AL; Stephens CA; Scott ML; Cardelli JA
    Oncotarget; 2016 May; 7(22):32200-9. PubMed ID: 27058757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion.
    Ren Y; Jia HH; Xu YQ; Zhou X; Zhao XH; Wang YF; Song X; Zhu ZY; Sun T; Dou Y; Tian WP; Zhao XL; Kang CS; Mei M
    Mol Cancer; 2018 Jan; 17(1):5. PubMed ID: 29325547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation.
    Jena BC; Das CK; Banerjee I; Bharadwaj D; Majumder R; Das S; Biswas A; Kundu M; Roy PK; Kundu CN; Mandal M
    Exp Cell Res; 2022 Aug; 417(1):113195. PubMed ID: 35561786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-Associated Fibroblast-Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression.
    Song M; He J; Pan QZ; Yang J; Zhao J; Zhang YJ; Huang Y; Tang Y; Wang Q; He J; Gu J; Li Y; Chen S; Zeng J; Zhou ZQ; Yang C; Han Y; Chen H; Xiang T; Weng DS; Xia JC
    Hepatology; 2021 May; 73(5):1717-1735. PubMed ID: 33682185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
    Yoshida GJ
    J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.
    Wu F; Yang J; Liu J; Wang Y; Mu J; Zeng Q; Deng S; Zhou H
    Signal Transduct Target Ther; 2021 Jun; 6(1):218. PubMed ID: 34108441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.
    Yeung TL; Leung CS; Wong KK; Samimi G; Thompson MS; Liu J; Zaid TM; Ghosh S; Birrer MJ; Mok SC
    Cancer Res; 2013 Aug; 73(16):5016-28. PubMed ID: 23824740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment.
    Anajafi S; Paryan M; Khoshnazar A; Soleimani M; Mohammadi-Yeganeh S
    Endocr Metab Immune Disord Drug Targets; 2024; 24(3):333-347. PubMed ID: 37612874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts.
    Shi X; Young CD; Zhou H; Wang X
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33322749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
    Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
    Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.
    Liu J; Chen S; Wang W; Ning BF; Chen F; Shen W; Ding J; Chen W; Xie WF; Zhang X
    Cancer Lett; 2016 Aug; 379(1):49-59. PubMed ID: 27216982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta in CAF-mediated tumor growth and metastasis.
    Calon A; Tauriello DV; Batlle E
    Semin Cancer Biol; 2014 Apr; 25():15-22. PubMed ID: 24412104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells.
    Shi Y; Sun L; Zhang R; Hu Y; Wu Y; Dong X; Dong D; Chen C; Geng Z; Li E; Fan Y
    J Exp Clin Cancer Res; 2021 Jan; 40(1):14. PubMed ID: 33407730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active autophagy in cancer-associated fibroblasts: Recent advances in understanding the novel mechanism of tumor progression and therapeutic response.
    Jena BC; Rout L; Dey A; Mandal M
    J Cell Physiol; 2021 Nov; 236(11):7887-7902. PubMed ID: 34008184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGFβ Signaling.
    Ringuette Goulet C; Bernard G; Tremblay S; Chabaud S; Bolduc S; Pouliot F
    Mol Cancer Res; 2018 Jul; 16(7):1196-1204. PubMed ID: 29636362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance.
    Fiori ME; Di Franco S; Villanova L; Bianca P; Stassi G; De Maria R
    Mol Cancer; 2019 Mar; 18(1):70. PubMed ID: 30927908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.